跳至主要内容
临床试验/ITMCTR2023000011
ITMCTR2023000011招募中Unknown

Efficacy evaluation of Tongfeng Fang and its influence on reconstruction of gut microbiome and immune function in acute gouty arthritis

Xiyuan Hospital of China Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新:

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 70(—)
性别
All

入选标准

  • ?Those who meet the diagnostic criteria of primary acute gouty arthritis and the syndrome differentiation criteria of TCM damp-heat syndrome.
  • ? Male and female patients aged 18-70 years.
  • ?Acute onset, the course of the attack within 48 hours.
  • ?No relevant therapeutic drugs have been taken since the onset of the disease.
  • ?Informed consent, voluntary subjects.

排除标准

  • ?Secondary gout, such as renal failure, tumor chemotherapy and/or radiotherapy;
  • ?Patients who were allergic to the drug in this study;
  • ?Have serious heart, liver, lung, hematopoietic system or affect their survival of serious diseases, such as tumor, AIDS; ALT or AST > 2N (N is the upper limit of normal); SCr=132mmol/L (1.5 mg/dl); Arrhythmia of clinical significance; white blood cell<3.0 times 10^9/L;
  • ?Joint lesions caused by rheumatoid arthritis, pyogenic arthritis, traumatic arthritis, psoriatic arthritis, pseudogout, lupus erythematosus and other diseases;
  • ?Hyperuricemia and gout caused by diuretics, compound antihypertensive drugs containing diuretics, ethambutol, pyrazinamide, aspirin and other drugs;
  • ?Hyperuricemia and gout caused by diuretics, compound antihypertensive drugs containing diuretics, ethambutol, pyrazinamide, aspirin and other drugs;
  • ?Pregnant and lactating women;
  • ?Suspected or indeed a history of alcohol or drug abuse, or according to the judgment of the researchers, with the possibility of reducing or complicating the inclusion of other lesions, such as frequent changes in the working environment and other easy to cause the loss of follow-up.

研究者

相似试验